Grant: Project Grant - PA: Nutrition, Metabolism and Diabetes
Université Laval
$100,000.00
Microbiome and liver mechanisms underlying the impact of dietary proteins on obesity and insulin resistance
EF 2021-22
Résumé
Obesity and type 2 diabetes (T2D) are chronic diseases that affect millions of people worldwide. A variety of diets have been proposed to offset obesity and T2D but the focus has been mainly to reduce fat and carbohydrates. However, very little consideration is given to the composition of dietary proteins and how they can impact weight gain and T2D risk. We now wish to further explore the role of dietary proteins in obesity-linked insulin resistance and T2D.
We will design new diets containing diversified protein sources from either meat, dairy, or plant-based and test their influence on obesity and T2D in mice fed dietary fat to promote obesity.
Research objectives are to:
1) To determine whether intestinal production of branched-chair fatty acids (BCFA) mediates the metabolic effect of dietary proteins by activating liver mTORC1, a nutrient sensing complex, and altering hepatic glucose metabolism.
2) To assess whether dietary proteins and BCFA alter mitochondrial lipid oxidation through nitrogen sensing mechanisms and increased urea cycle activity in the liver
3) To determine whether the abundance of intestinal bacterium Akkermansia muciniphila and its impact on intestinal GLP-1 production and activation of brown adipose tissue are involved in the metabolic effect of dietary proteins
These studies will be performed in both male and female mice, using dietary and genetic mouse models and using microbiome technologies and relevant organs to identify new therapeutic targets causally related to the impact of dietary proteins on obesity, insulin resistance and T2D.
This research represents a major leap forward in the molecular understanding of how specific protein sources or their components impact on obesity and insulin resistance. We hope these studies will help define novel dietary strategies for the prevention and treatment of obesity-linked metabolic diseases.
Programme
Project Grant - PA: Nutrition, Metabolism and Diabetes
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
456675
Name
Marette André
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Nutrition, Food & Health
Projecttitle
Microbiome and liver mechanisms underlying the impact of dietary proteins on obesity and insulin resistance
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Nutrition, Metabolism and Diabetes
Keyworddelim
Dietary Proteins; Diets; Glucose Metabolism; Insulin Resistance; Insulin Signaling; Lipid Metabolism; Liver Metabolism; Microbiome; Obesity; Short Chain Fatty Acids
Abstract
Obesity and type 2 diabetes (T2D) are chronic diseases that affect millions of people worldwide. A variety of diets have been proposed to offset obesity and T2D but the focus has been mainly to reduce fat and carbohydrates. However, very little consideration is given to the composition of dietary proteins and how they can impact weight gain and T2D risk. We now wish to further explore the role of dietary proteins in obesity-linked insulin resistance and T2D.
We will design new diets containing diversified protein sources from either meat, dairy, or plant-based and test their influence on obesity and T2D in mice fed dietary fat to promote obesity.
Research objectives are to:
1) To determine whether intestinal production of branched-chair fatty acids (BCFA) mediates the metabolic effect of dietary proteins by activating liver mTORC1, a nutrient sensing complex, and altering hepatic glucose metabolism.
2) To assess whether dietary proteins and BCFA alter mitochondrial lipid oxidation through nitrogen sensing mechanisms and increased urea cycle activity in the liver
3) To determine whether the abundance of intestinal bacterium Akkermansia muciniphila and its impact on intestinal GLP-1 production and activation of brown adipose tissue are involved in the metabolic effect of dietary proteins
These studies will be performed in both male and female mice, using dietary and genetic mouse models and using microbiome technologies and relevant organs to identify new therapeutic targets causally related to the impact of dietary proteins on obesity, insulin resistance and T2D.
This research represents a major leap forward in the molecular understanding of how specific protein sources or their components impact on obesity and insulin resistance. We hope these studies will help define novel dietary strategies for the prevention and treatment of obesity-linked metabolic diseases.
Competitiondate
202109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Marette, André
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~